Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2010 1
2011 2
2012 1
2016 2
2018 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer.
Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME. Klett-Mingo JI, et al. Cancers (Basel). 2022 Dec 30;15(1):227. doi: 10.3390/cancers15010227. Cancers (Basel). 2022. PMID: 36612223 Free PMC article.
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment.
Carrión-Marchante R, Pinto-Díez C, Klett-Mingo JI, Palacios E, Barragán-Usero M, Pérez-Morgado MI, Pascual-Mellado M, Alcalá S, Ruiz-Cañas L, Sainz B Jr, González VM, Martín ME. Carrión-Marchante R, et al. Among authors: perez morgado mi. Pharmaceutics. 2023 Apr 18;15(4):1273. doi: 10.3390/pharmaceutics15041273. Pharmaceutics. 2023. PMID: 37111758 Free PMC article.
Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer.
Pinto-Díez C, García-Recio EM, Pérez-Morgado MI, García-Hernández M, Sanz-Criado L, Sacristán S, Toledo-Lobo MV, Pérez-Mies B, Esteban-Rodríguez I, Pascual A, Garcia-Villanueva M, Martínez-Jañez N, González VM, Martín ME. Pinto-Díez C, et al. Among authors: perez morgado mi. Oncotarget. 2018 Feb 5;9(17):13501-13516. doi: 10.18632/oncotarget.24417. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568373 Free PMC article.
eIF4F complex disruption causes protein synthesis inhibition during hypoxia in nerve growth factor (NGF)-differentiated PC12 cells.
Hernández-Jiménez M, Ayuso MI, Pérez-Morgado MI, García-Recio EM, Alcázar A, Martín ME, González VM. Hernández-Jiménez M, et al. Among authors: perez morgado mi. Biochim Biophys Acta. 2012 Feb;1823(2):430-8. doi: 10.1016/j.bbamcr.2011.11.008. Epub 2011 Dec 6. Biochim Biophys Acta. 2012. PMID: 22178387 Free article.